Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of 12.04% and Operating profit at -1.99% over the last 5 years
2
With a fall in Net Sales of -16.4%, the company declared Very Negative results in Sep 25
3
With ROE of 18.90%, it has a very expensive valuation with a 11.10 Price to Book Value
Stock DNA
Chemicals & Petrochemicals
CNY 20,050 Million (Large Cap)
59.00
NA
0.78%
0.23
15.98%
13.31
Revenue and Profits:
Net Sales:
264 Million
(Quarterly Results - Mar 2026)
Net Profit:
13 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-31.22%
0%
-31.22%
6 Months
-34.53%
0%
-34.53%
1 Year
-27.96%
0%
-27.96%
2 Years
39.39%
0%
39.39%
3 Years
42.32%
0%
42.32%
4 Years
40.32%
0%
40.32%
5 Years
52.36%
0%
52.36%
Dalian Bio-Chem Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.04%
EBIT Growth (5y)
-1.99%
EBIT to Interest (avg)
59.48
Debt to EBITDA (avg)
0.11
Net Debt to Equity (avg)
0.07
Sales to Capital Employed (avg)
0.59
Tax Ratio
13.73%
Dividend Payout Ratio
62.61%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
26.57%
ROE (avg)
21.30%
Valuation key factors
Factor
Value
P/E Ratio
59
Industry P/E
Price to Book Value
11.10
EV to EBIT
55.66
EV to EBITDA
43.77
EV to Capital Employed
8.90
EV to Sales
12.30
PEG Ratio
NA
Dividend Yield
0.89%
ROCE (Latest)
15.99%
ROE (Latest)
18.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Sep'25
Change(%)
Net Sales
263.60
307.20
-14.19%
Operating Profit (PBDIT) excl Other Income
23.90
45.30
-47.24%
Interest
9.30
8.30
12.05%
Exceptional Items
0.00
0.00
Consolidate Net Profit
12.50
31.20
-59.94%
Operating Profit Margin (Excl OI)
90.70%
147.50%
-5.68%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -14.19% vs 2.33% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -59.94% vs -29.89% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,296.90
1,052.60
23.21%
Operating Profit (PBDIT) excl Other Income
445.00
427.20
4.17%
Interest
7.60
5.30
43.40%
Exceptional Items
0.10
0.00
Consolidate Net Profit
358.80
328.40
9.26%
Operating Profit Margin (Excl OI)
289.70%
345.10%
-5.54%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 23.21% vs -15.23% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 9.26% vs -18.43% in Dec 2023
About Dalian Bio-Chem Co., Ltd. 
Dalian Bio-Chem Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






